Jaguar Health closes $3.45M convertible note private placement with warrants

Jaguar Health, Inc.

Issued $3.448M aggregate principal of convertible notes; 6% interest, 3-month maturity, immediately convertible.
Warrants to purchase up to 622,584 shares of common stock; 5-year term, exercisable immediately.
Participants include CEO Lisa Conte, board members, and senior executives alongside institutional investors.
H.C. Wainwright acted as exclusive placement agent; net proceeds for working capital and general corporate purposes.
Company agreed to file a resale registration statement covering shares underlying the notes and warrants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.